Clinical Trials Browser

Phase 2 × Advanced Triple-Negative Breast Cancer × Breast × Clear all

NCT06685796 2024-11-13

A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer

Phase 2 Recruiting

Advanced Triple-Negative Breast Cancer

NCT03254654 2022-04-20

Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer

Phase 2 Completed

Advanced Triple-Negative Breast Cancer